Education
About Us
Working with TipRanks
Follow Us
Theravance Biopharma (TBPH)
NASDAQ:TBPH
TBPH Analyst Ratings
Moderate Buy
3 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TBPH Stock 12 Month Forecast
Average Price Target
$16.13
▲(15.79% Upside)
| Highest Price Target$21.00 | Average Price Target$16.13 | Lowest Price Target$13.67 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
$42→$17
Buy
22.04%
Upside
Assigned
03/05/26
Oppenheimer
$27→$13.67
Hold
-1.87%
Downside
Downgraded
03/05/26
H.C. Wainwright
$27→$15
Buy
7.68%
Upside
Assigned
03/04/26
B. Riley Securities
$28→$14
Hold
0.50%
Upside
Downgraded
03/04/26
BTIG
$40→$21
Buy
50.75%
Upside
Reiterated
03/03/26
TD Cowen
$13
Hold
-6.68%
Downside
Reiterated
11/11/25
Leerink Partners
$10→$13
Hold
-6.68%
Downside
Reiterated
08/13/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
$42→$17
Buy
22.04%
Upside
Assigned
03/05/26
Oppenheimer
$27→$13.67
Hold
-1.87%
Downside
Downgraded
03/05/26
H.C. Wainwright
$27→$15
Buy
7.68%
Upside
Assigned
03/04/26
B. Riley Securities
$28→$14
Hold
0.50%
Upside
Downgraded
03/04/26
BTIG
$40→$21
Buy
50.75%
Upside
Reiterated
03/03/26
TD Cowen
$13
Hold
-6.68%
Downside
Reiterated
11/11/25
Leerink Partners
$10→$13
Hold
-6.68%
Downside
Reiterated
08/13/25
Best Analysts Covering Theravance Biopharma
3 Months
xxx
Success Rate
4/6 ratings generated profit
Average Return
+2.60%
assigned a xxx
rating 13 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +2.60% per trade.
1 Year
Success Rate
3/6 ratings generated profit
Average Return
-7.18%
assigned a buy rating 13 days ago
Copying Debanjana Chatterjee's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -7.18% per trade.
2 Years
xxx
Success Rate
12/17 ratings generated profit
Average Return
+28.52%
assigned a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.59% of your transactions generating a profit, with an average return of +28.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TBPH Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
3
5
5
5
3
Buy
15
19
23
10
7
Hold
18
20
22
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
44
50
19
14
Each month's total comprises the sum of three months' worth of ratings.
TBPH Financial Forecast
TBPH Stock Forecast FAQ
What is TBPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Theravance Biopharma’s 12-month average price target is 16.13.
What is TBPH’s upside potential, based on the analysts’ average price target?
Theravance Biopharma has 15.79% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TBPH a Buy, Sell or Hold?
Theravance Biopharma has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings.
What is Theravance Biopharma’s price target?
The average price target for Theravance Biopharma is 16.13. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $21.00 ,the lowest forecast is $13.67. The average price target represents 15.79% Increase from the current price of $13.93.
The highest analyst price target is $21.00 ,the lowest forecast is $13.67. The average price target represents 15.79% Increase from the current price of $13.93.
What do analysts say about Theravance Biopharma?
Theravance Biopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of TBPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.